A PILOT RANDOMISED CROSSOVER TRIAL OF ANGIOTENSIN II FOR THE PREVENTION AND TREATMENT OF MUSCLE CRAMPS IN MAINTENANCE HAEMODIALYSIS PATIENTS: THE CRAMP HD STUDY

A PILOT RANDOMISED CROSSOVER TRIAL OF ANGIOTENSIN II FOR THE PREVENTION AND TREATMENT OF MUSCLE CRAMPS IN MAINTENANCE HAEMODIALYSIS PATIENTS: THE CRAMP HD STUDY

Dr Emily See1, Dr Atthaphong Phongphithakchai2, A/Prof Peter Mount2, A/Prof Rinaldo Bellomo2

1Royal Melbourne Hospital, Parkville, Australia, 2Austin Health, Heidelberg, Australia

Aim: To test whether angiotensin II infusion during intermittent haemodialysis (IHD) is safe, feasible, and effective in the prevention and attenuation of muscle cramps.

Background: The action of angiotensin II on pre- and post-capillary vessels may reduce skeletal muscle ischemia during IHD and decrease the incidence and/or intensity of IHD-related muscle cramps.

Methods: We performed a pilot, single-blinded, randomised crossover trial of patients receiving IHD who frequently experience intradialytic muscle cramps. Patients were randomly allocated to receive either intravenous angiotensin II or placebo for the duration of their first dialysis session of the week. They crossed over to the alternate arm each week for the next four weeks. The primary outcome of the trial was safety. Secondary outcomes included cramp-related symptoms, haemodynamic parameters, dialysis prescription alterations, and biomarkers.

Results: We studied 24 sessions in six patients. Intradialytic hypertension occurred during 4 angiotensin II sessions and 2 placebo sessions (33% vs 17%, P=0.64). There were no other adverse events. Compared with placebo, muscle cramps occurred less often with angiotensin II (30% vs. 90% sessions, P=0.009). Median cramp intensity was also significantly lower with angiotensin II (Brief Pain Inventory (BPI) score: 1.4 vs. 5.3; P<0.001), as was median maximal cramp intensity (BPI score: 1.2 vs. 6.0; P<0.001). During angiotensin II infusion, the occurrence of fluid bolus administration due to cramps was decreased (P=0.037). Angiotensin II increased blood pressure and heart rate but not cardiac output or levels of troponin, creatine kinase or renin.

Conclusions: Intravenous angiotensin II infusion during IHD appears safe and effective in reducing intradialytic muscle cramps. These observations justify further investigation of this intervention in larger controlled studies.

Presentation Slides PDF – Click here

Biography:

Dr Emily See is a Consultant Intensivist and Nephrologist at the Royal Melbourne Hospital, a Senior Honorary Fellow at the University of Melbourne, and an Adjunct Senior Research Fellow at Monash University. She holds a Master of Medical Statistics degree from the University of Oxford and a PhD in Clinical Medicine from the University of Melbourne. Her clinical and research interests centre around acute kidney injury, continuous renal replacement therapy, and sepsis.

 

 

Categories